Exploring how different amounts of physical activity affect arthritis symptoms
Official title: Examination of the Dose Response Relationship Between Physical Activity and Arthritis-Attributable Outcomes
Funded at University of South Carolina at Columbia · NIH-11046169 · Data updated 2026-11-12
This study is looking at how different amounts of exercise can help adults with arthritis feel better, and it’s for anyone who wants to find out how much activity they need to improve their pain and daily life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 30, 2024 |
| Project end | September 29, 2029 |
| Funding year | 2024 |
| Award (this year) | $249,764 |
| NIH project number | 1U48DP006850-01 |
| Project ID | NIH-11046169 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults diagnosed with arthritis who are currently not meeting physical activity guidelines and are seeking ways to manage their symptoms.
✕Less likely to help
Patients with severe mobility limitations or those unable to engage in any physical activity may not benefit from this research.
What this research studies
This research investigates how varying doses of moderate-to-vigorous physical activity (MVPA) impact outcomes related to arthritis in adults. It aims to determine the minimal amount of activity needed to improve symptoms such as pain, physical function, and quality of life. Participants will engage in different levels of physical activity (45, 90, or 150 minutes per week) and report their experiences over a period of 6 to 12 months. The study seeks to provide tailored recommendations for those struggling to meet standard activity guidelines.
Why it matters
Potential benefit: If successful, this research could help identify achievable physical activity goals that improve arthritis symptoms and overall well-being.
How similar studies have gone: Previous research has shown that physical activity can improve arthritis symptoms, but this study aims to refine the understanding of the specific doses needed for optimal outcomes.
Where this research is happening
-
University of South Carolina at Columbia
Columbia, United States Active
Researchers
- Principal investigator: Pellegrini, Christine Ann — University of South Carolina at Columbia
- Study coordinator: Pellegrini, Christine Ann
Related research
Other NIH-funded projects on the same topics.
-
Gut microbes and methotrexate: boosting RA treatment through microbiome targets
Researchers are studying how gut bacteria affect how well methotrexate works for people with rheumatoid arthritis, aiming to make MTX effective for more patients.
-
Understanding how immune checkpoint drugs can trigger inflammatory arthritis in cancer patients
This research looks at why some cancer patients develop inflammatory arthritis after PD-1 inhibitor therapy and what could be done to prevent it.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
-
Dose guide for physical activity to improve arthritis symptoms
A study from the University of South Carolina will look at how different amounts of weekly physical activity affect arthritis symptoms and quality of life in adults with arthritis.
-
Collaborating Center for Arthritis Care Tools and a Coordinating Center for an Arthritis Management & Wellbeing Network
A coordinated NIH program aims to improve how primary care providers refer people with arthritis to evidence-based, self-management programs and to boost participation, especially among groups facing disparities.
-
Arthritis prevention program to help adults with OA in mountain west communities
A program to help adults with osteoarthritis in the Mountain West connect with physical activity counseling and community activities to reduce activity limitations.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.